Agios Pharmaceuticals, Inc. (AGIO) Operating margin 2016–2025
Agios Pharmaceuticals, Inc. (AGIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-873.9%FY2025 · since FY2016: -287.6% → -873.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -873.9% | +292.6 pp |
| FY2024 | -1166.5% | +293.1 pp |
| FY2023 | -1459.5% | +1272.6 pp |
| FY2022 | -2732.1% | — |
| FY2019 | -268.2% | +115.8 pp |
| FY2018 | -384.0% | +361.8 pp |
| FY2017 | -745.8% | -458.3 pp |
| FY2016 | -287.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice